Molecular characterization and expression of equine testicular cytochrome P450 aromatase

被引:12
作者
Seralini, GE [1 ]
Tomilin, A [1 ]
Auvray, P [1 ]
Nativelle-Serpentini, C [1 ]
Sourdaine, P [1 ]
Moslemi, S [1 ]
机构
[1] Univ Caen, Biochem & Mol Biol Lab, IBBA, EA 2608, F-14032 Caen, France
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION | 2003年 / 1625卷 / 03期
关键词
aromatase; cytochrome P450; horse; testis; cDNA cloning; steroid;
D O I
10.1016/S0167-4781(02)00621-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We characterized testicular equine aromatase and its expression. A 2707 bp cDNA was isolated, it encoded a polypeptide of 503 residues with a deduced molecular mass of 57.8 kDa. The sequence features were those of a cytochrome P450 aromatase, with a 78% polypeptide identity with the human counterpart. The gene has a minimal length of 74 kb comprising at least 9 exons and expresses a 2.8 kb mRNA in the testis. Transient cDNA transfections in E293 cells and in vitro translations in a reticulocyte lysate system allowed aromatase protein and activity detections. The activity increased with androstenedione as substrate in a dose-dependent manner. The isolation of testicular aromatase by a new immunoaffinity method demonstrated that the protein could exist either glycosylated or not with a 2 kDa difference. All these results taken together allow new structural studies to progress in the understanding of this cytochrome P450. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:229 / 238
页数:10
相关论文
共 44 条
[1]   IMMUNOHISTOCHEMICAL LOCALIZATION OF CYTOCHROME-P450 AROMATASE IN EQUINE GONADS [J].
ALMADHIDI, J ;
SERALINI, GE ;
FRESNEL, J ;
SILBERZAHN, P ;
GAILLARD, JL .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1995, 43 (06) :571-577
[2]  
AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303
[3]   PAAn-1b and PAAn-E:: Two phosphorothioate antisense oligodeoxynucleotides inhibit human aromatase gene expression [J].
Auvray, P ;
Sourdaine, P ;
Séralini, GE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 253 (01) :1-9
[4]   Study of substrate specificity of human aromatase by site directed mutagenesis [J].
Auvray, P ;
Nativelle, C ;
Bureau, R ;
Dallemagne, P ;
Séralini, GE ;
Sourdaine, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (05) :1393-1405
[5]   Evidence for new non-steroidal human aromatase inhibitors and comparison with equine aromatase inhibition for an understanding of the mammalian active site [J].
Auvray, P ;
Moslemi, S ;
Sourdaine, P ;
Galopin, S ;
Séralini, GE ;
Enguehard, C ;
Dallemagne, P ;
Bureau, R ;
Sonnet, P ;
Rault, S .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (06) :451-462
[6]  
BACKES WL, 1993, HDB EXP PHARM, V105, P15
[7]  
Balthazart J, 1996, J NEUROBIOL, V31, P129, DOI 10.1002/(SICI)1097-4695(199610)31:2<129::AID-NEU1>3.3.CO
[8]  
2-2
[9]   Dual regulation of promoter II- and promoter 1f-derived cytochrome P450 aromatase transcripts equine granulosa cells during human chorionic gonadotropin-induced ovulation: A novel model for the study of aromatase promoter switching [J].
Boerboom, D ;
Kerban, A ;
Sirois, J .
ENDOCRINOLOGY, 1999, 140 (09) :4133-4141
[10]   Effect of testosterone and estradiol in a man with aromatase deficiency [J].
Carani, C ;
Qin, K ;
Simoni, M ;
FaustiniFustini, M ;
Serpente, S ;
Boyd, J ;
Korach, KS ;
Simpson, ER .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (02) :91-95